Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T83202 Target Info
Target Name Ribosomal protein S6 kinase alpha-1 (RSK1)
Synonyms p90S6K; p90RSK1; p90-RSK 1; S6K-alpha-1; Ribosomal S6 kinase 1; RSK-1; MAPKAPK1A; MAPKAPK-1a; MAPKAP kinase 1a; MAPK-activated protein kinase 1a; MAP kinase-activated protein kinase 1a; 90 kDa ribosomal protein S6 kinase 1
Target Type Patented-recorded Target
Gene Name RPS6KA1
Biochemical Class Kinase
UniProt ID
KS6A1_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US8592433
Title Compounds and Compositions As Protein Kinase Inhibitors.
Representative Drug(s) D0R0DW Drug Info N.A. [1]
Patent ID US8183248
Title Substituted Purrolo[2,3-D]Pyrimidines and Compositions As Protein Kinase Inhibitors.
Representative Drug(s) D0T2CA Drug Info N.A. [1]
Patent ID US8101608
Title Compounds and Compositions As Protein Kinase Inhibitors.
Representative Drug(s) D08QMJ Drug Info N.A. [1]
Patent ID US7868018
Title Compounds and Compositions As Protein Kinase Inhibitors.
Representative Drug(s) D0I3YK Drug Info N.A. [1]
Patent ID US7623038
Title Compounds and Compositions As Protein Kinase Inhibitors.
Representative Drug(s) D00RPW Drug Info N.A. [1]
Patent ID US7605241
Title Synthesis of Inhibitors of P90Rsk.
References  Top
REF 1 Ribosomal S6 kinase (RSK) modulators: a patent review.Expert Opin Ther Pat. 2016 Sep;26(9):1061-78.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.